The present study aimed to check whether serum clusterin (CLU) concentration and its glycosylation pattern may be markers differentiating these diseases—blood sera of patients with PsA (n = 37), RA (n = 34), and healthy subjects (control, n = 21) were examined. This evidence concerns the gene CLU and rheumatoid arthritis.